The reiteration of a Buy rating combined with an increased price target by a reputable analyst like Dae Gon Ha suggests a strong bullish sentiment towards Krystal Biotech. This is likely to positively influence investor perception and could lead to a short-term increase in the stock price as market participants adjust their valuations based on the new price target.